- Home
- SSYS vs SAGE Comparison
SSYS vs SAGE Comparison
Compare SSYS & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- SAGE
- Stock Information
- Founded
- SSYS 1989
- SAGE 2010
- Country
- SSYS United States
- SAGE United States
- Employees
- SSYS 1980
- SAGE N/A
- Industry
- SSYS Computer peripheral equipment
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- SSYS Technology
- SAGE Health Care
- Exchange
- SSYS Nasdaq
- SAGE Nasdaq
- Market Cap
- SSYS 534.6M
- SAGE 462.2M
- IPO Year
- SSYS 1994
- SAGE 2014
- Fundamental
- Price
- SSYS $7.31
- SAGE $6.51
- Analyst Decision
- SSYS Strong Buy
- SAGE Hold
- Analyst Count
- SSYS 4
- SAGE 20
- Target Price
- SSYS $10.75
- SAGE $15.89
- AVG Volume (30 Days)
- SSYS 388.7K
- SAGE 586.7K
- Earning Date
- SSYS 11-14-2024
- SAGE 10-29-2024
- Dividend Yield
- SSYS N/A
- SAGE N/A
- EPS Growth
- SSYS N/A
- SAGE N/A
- EPS
- SSYS N/A
- SAGE N/A
- Revenue
- SSYS $600,561,000.00
- SAGE $97,243,000.00
- Revenue This Year
- SSYS N/A
- SAGE N/A
- Revenue Next Year
- SSYS $4.53
- SAGE $144.27
- P/E Ratio
- SSYS N/A
- SAGE N/A
- Revenue Growth
- SSYS N/A
- SAGE 837.55
- 52 Week Low
- SSYS $6.05
- SAGE $5.84
- 52 Week High
- SSYS $14.93
- SAGE $28.26
- Technical
- Relative Strength Index (RSI)
- SSYS 51.28
- SAGE 68.33
- Support Level
- SSYS $6.92
- SAGE $7.33
- Resistance Level
- SSYS $8.11
- SAGE $7.83
- Average True Range (ATR)
- SSYS 0.29
- SAGE 0.40
- MACD
- SSYS 0.00
- SAGE 0.21
- Stochastic Oscillator
- SSYS 49.58
- SAGE 91.20
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.